Related by context. All words. (Click for frequent words.) 70 chronic HCV infection 69 hepatitis C virus HCV 68 chronic hepatitis C. 67 HCV genotype 1 67 hepatitis C HCV 66 chronic HCV 66 virus HCV infection 65 chronic hepatitis B 65 HCV 65 hepatitis C virus 64 pegylated interferon 63 chronic HCV genotype 63 hepatitis C genotype 63 CCR5 tropic HIV 62 HCV infected 62 virus HCV 61 peginterferon 61 ribavirin 61 chronic hepatitis B. 61 HBeAg positive 61 nitazoxanide 60 Amigal 60 HCV infection 60 TMC# [001] 60 hepatitis C 60 protease inhibitor PI 59 raltegravir 59 Ribavirin 59 ribavirin therapy 59 HBeAg negative 59 alfa 2a 59 hepatitis B virus HBV 59 treatment naive genotype 59 pegylated interferon alfa 2a 59 HCV SPRINT 59 refractory gout 58 pegylated interferon alpha 58 pegylated alpha interferon 58 lupus nephritis 58 peginterferon alfa 2a 58 antiretroviral agents 58 Chronic Hepatitis C 58 mRCC 58 lamivudine 58 null responder HCV 58 Pegasys ® 58 chronic HBV 58 Chronic Idiopathic Constipation 58 relapsed multiple myeloma 58 Reverset 57 PegIFN RBV 57 nucleotide analogue 57 ribavirin RBV 57 plus ribavirin 57 pegylated interferon alfa 57 Clevudine 57 Hepatitis C HCV 57 treatment naïve genotype 57 invasive candidiasis 57 metastatic renal cell carcinoma 57 chronic HBV infection 57 telaprevir 57 Copegus ribavirin 57 chronically infected 57 Hepatitis C virus HCV 57 Pegasys peginterferon alfa 2a 57 albinterferon alfa 2b 57 COPEGUS ribavirin 57 interferon alfa 57 relapsed refractory multiple myeloma 57 hepatitis B HBV 57 ACTEMRA TM 57 boosted protease inhibitor 57 hyperuricemia 56 sorafenib Nexavar 56 CCR5 antagonist 56 cIAI 56 PREZISTA r 56 Recombinant interferon alpha 56 protease inhibitor 56 Viread tenofovir disoproxil fumarate 56 advanced hepatocellular carcinoma 56 pegylated interferons 56 Rheumatoid Arthritis RA 56 Alinia 56 recurrent genital herpes 56 nucleoside analogue 56 BARACLUDE ® 56 interferon therapy 56 sorafenib tablets 56 peginterferon alfa 2b 56 achieve sustained virologic 56 Pegasys plus Copegus 56 chronic hepatitis 56 primary hypercholesterolemia 56 oropharyngeal candidiasis OPC 56 chronic ITP 56 posaconazole 56 decompensated liver disease 56 HCV genotype 56 interferon 56 leukemia CLL 56 PEG INTRON R 56 bendamustine 56 Telaprevir 56 SCH # 56 transcriptase inhibitor NNRTI 56 onychomycosis 56 entecavir 56 telbivudine 56 OncoVEX GM CSF 56 SHPT 56 achieved sustained virologic 55 symptomatic BPH 55 ALN RSV# 55 Boceprevir 55 forodesine 55 invasive aspergillosis 55 HCV genotypes 55 CANCIDAS 55 HCV infections 55 HBeAg negative chronic hepatitis 55 VFEND 55 Sebivo 55 viral kinetics 55 null responder 55 INTELENCE 55 non nucleoside reverse 55 TYZEKA 55 Tyzeka 55 investigational compound 55 terlipressin 55 pancreatic NET 55 celgosivir 55 OHR/AVR# 55 lamivudine refractory patients 55 leukemia AML 55 zidovudine AZT 55 maraviroc 55 doripenem 55 diabetic neuropathic pain 55 NNRTI 55 HIV infected 55 BCX# 55 Chronic Hepatitis B 55 Plicera 55 Viramidine 55 polymerase inhibitor 55 tenofovir disoproxil fumarate 55 prostate cancer HRPC 55 ribavirin Copegus 55 doxorubicin HCl liposome injection 55 post herpetic neuralgia PHN 55 Pegasys R 55 Cethromycin 55 tocilizumab 55 peginterferon alpha 2a 55 PEG Interferon lambda 55 IDX# 55 eosinophilic asthma 55 postoperative ileus 54 Peg IFN 54 chronic ITP patients 54 interferon alpha 54 plus COPEGUS 54 Traficet EN 54 hepatitis C. 54 diabetic gastroparesis 54 lenalidomide Revlimid R 54 cSSSI 54 protease inhibitor telaprevir 54 Hepatitis C virus 54 interferon alfa 2b 54 sustained virologic response 54 NOXAFIL 54 etravirine 54 Velcade bortezomib 54 Sprycel dasatinib 54 rituximab refractory 54 Diabetic Macular Edema 54 pafuramidine 54 castration resistant prostate cancer 54 Gemzar ® 54 virus HCV protease inhibitor 54 PEGINTRON TM 54 Actemra tocilizumab 54 diarrhea predominant irritable 54 tenofovir emtricitabine 54 castrate resistant prostate cancer 54 ritonavir boosted 54 null responders 54 naïve HCV 54 RDEA# 54 AA Amyloidosis 54 micafungin 54 lopinavir ritonavir 54 perifosine 54 Chronic hepatitis C 54 INVANZ 54 Tipranavir 54 peginterferon alfa 2a Pegasys 54 CMV disease 54 indolent NHL 54 pancreatic insufficiency 54 TMC# C# 54 DEB# 54 TORISEL 54 e antigen HBeAg 54 dasatinib Sprycel ® 54 TYGACIL 54 relapsing multiple sclerosis 54 investigational integrase inhibitor 54 pramlintide 54 Aptivus ® 54 efalizumab 54 Civacir 54 refractory multiple myeloma 54 Pradefovir 54 lupus renal disease 54 LymphoStat B belimumab 54 AEGR 54 YONDELIS 54 Roche Pegasys 54 valopicitabine 54 telaprevir VX 54 advanced NSCLC 54 ISENTRESS 54 chronic lymphocytic leukemia CLL 54 diagnosed multiple myeloma 54 Myelodysplastic Syndrome MDS 54 AEG# 54 pradefovir 54 metastatic RCC 54 docetaxel Taxotere ® 54 systemic fungal infections 54 Phase 2b clinical 54 Clostridium difficile associated 54 naive HCV 53 sorafenib Nexavar R 53 telaprevir dosed 53 Hepatitis C Virus HCV 53 Genasense ® 53 voriconazole 53 LymphoStat B 53 candidemia 53 recurrent glioblastoma multiforme 53 adult chronic ITP 53 atazanavir sulfate 53 achieved sustained virological 53 zidovudine lamivudine 53 stage IIIB 53 invasive fungal infections 53 immunomodulator 53 refractory AML 53 HCV RESPOND 2 53 SUTENT 53 Elvitegravir 53 cutaneous T 53 pediatric Crohn disease 53 alpha 2a 53 overactive bladder OAB 53 ceftazidime 53 dasatinib Sprycel 53 infliximab 53 esophageal candidiasis 53 Sustiva efavirenz 53 relapsed MM 53 TEMODAL 53 CIMZIA ™ 53 TNF antagonist 53 pegylated interferon alpha 2a 53 cell lymphoma CTCL 53 nosocomial pneumonia 53 pomalidomide 53 APTIVUS r 53 coinfected 53 BARACLUDE R 53 dacarbazine 53 interferon alfa 2a 53 PegIntron 53 LEXIVA r 53 naive HCV genotype 53 nucleotide analog 53 visilizumab 53 metastatic hormone refractory 53 CCR5 tropic 53 relapsing remitting multiple sclerosis 53 Peginterferon 53 Hepsera 53 PEGINTRON 53 HuMax CD4 53 Omacetaxine 53 mixed dyslipidemia 53 latent tuberculosis 53 Ceflatonin R 53 erlotinib Tarceva ® 53 PEG interferon 53 purpura ITP 53 metastatic renal cell 53 anti TNF 53 bevirimat 53 amrubicin 53 standard chemotherapy regimen 53 CHOP chemotherapy 53 Pemetrexed 53 inhibitor RG# 53 fidaxomicin 53 BEXXAR 53 BENLYSTA TM 53 S. aureus infections 53 human immunodeficiency virus 53 peg IFN 53 biologic therapy 53 Dasatinib 53 antiretroviral therapy 53 ceftaroline 53 hepatocellular carcinoma 53 Selzentry 53 ceftriaxone 53 PRTX 53 DU #b 53 Hepatitis C Virus 53 diabetic nephropathy 53 neurogenic orthostatic hypotension 53 lymphoma CTCL 53 relapsed ovarian cancer 53 elotuzumab 53 refractory CLL 53 daptomycin 53 HCV protease inhibitor 53 LTBI 53 antiretroviral naïve 53 AA amyloidosis 53 idiopathic pulmonary fibrosis IPF 53 metastatic castration resistant 53 abacavir lamivudine 53 Quinamed 53 nucleoside analog 53 interferon ribavirin 53 refractory chronic lymphocytic 53 antiviral therapy 53 Nexavar ® 53 aztreonam 53 carcinoid syndrome 53 acute myelogenous leukemia AML 53 Ceplene 53 antiretroviral naive 53 HspE7 53 ITMN 53 immunocompromised patients 53 Copegus 53 oritavancin 53 Racivir 53 dirucotide MBP# 53 Etravirine 53 SPRYCEL ® 53 trabectedin 53 Interferon alpha 52 Glufosfamide 52 tipranavir 52 relapsing MS 52 polymerase inhibitors 52 Copegus ® ribavirin 52 lopinavir ritonavir Kaletra 52 decitabine 52 plus dexamethasone 52 Phenoptin 52 CTAP# Capsules 52 sunitinib malate 52 AVELOX 52 temsirolimus 52 methotrexate MTX 52 acne vulgaris 52 ACTEMRA 52 abacavir Ziagen 52 hormone refractory prostate cancer 52 Noxafil 52 heavily pretreated 52 oral ridaforolimus 52 heterozygous FH 52 ABSSSI 52 Elacytarabine 52 superficial bladder cancer 52 relapsed refractory 52 monotherapy 52 Alemtuzumab 52 evaluating tivozanib 52 peginterferon alfa 52 disease modifying antirheumatic 52 Bronchitol 52 receiving immunosuppressive therapy 52 romiplostim 52 Fludara 52 adefovir 52 Peginterferon alfa 2a 52 Amrubicin 52 rilpivirine 52 STELARA TM 52 TREANDA 52 ZYVOX 52 Pafuramidine 52 KRN# 52 subcutaneously administered 52 VELCADE melphalan 52 minimally symptomatic 52 axitinib 52 leukemia ALL 52 pulmonary arterial hypertension 52 PRT# 52 Tamibarotene 52 HBeAg positive patients 52 lesinurad 52 sorafenib Nexavar ® 52 APTIVUS 52 ARIXTRA R 52 PKC# 52 boceprevir 52 prostate cancer CRPC 52 adalimumab Humira 52 Telbivudine 52 VELCADE 52 biologic DMARD 52 INCB# [001] 52 HQK 52 Telintra 52 Dapagliflozin 52 acyclovir Lauriad R 52 ARCALYST 52 chronic idiopathic constipation 52 Pegintron 52 HBV vaccine 52 Thiovir 52 non nucleoside inhibitor 52 Adalimumab 52 Albuferon 52 cidofovir 52 ZALBIN 52 Phase Ib 52 HIV coinfected 52 forodesine hydrochloride 52 NRTI resistance 52 darunavir 52 autoantibody positive 52 Altastaph 52 hepatitis C infection 52 basiliximab 52 phase IIb study 52 daily Infergen 52 talactoferrin 52 virologic failure 52 STELARA 52 VIR# 52 ketolide antibiotic 52 panitumumab Vectibix 52 sunitinib 52 thymosin alpha 1 52 Blinatumomab 52 non metastatic osteosarcoma 52 gefitinib 52 antisense drug 52 histone deacetylase HDAC inhibitor 52 oral antifungal 52 PrEP 52 Copegus R 52 DermaVir Patch 52 PEGASYS ® 52 Rebetol 52 Hepatitis C 52 subcutaneous formulation 52 Hodgkin lymphoma NHL 52 chronic plaque psoriasis 52 metastatic colorectal carcinoma 52 uncomplicated malaria 52 abiraterone 52 apricitabine 52 Lamivudine 52 mTOR inhibitor 52 AVASTIN 52 alpha interferon 52 acute decompensated heart 52 recurrent NSCLC 52 efavirenz Sustiva 52 amoxicillin clavulanate 52 relapsing remitting MS RRMS 52 Vandetanib 52 alkylating agent 52 sorafenib 52 metastatic melanoma 52 treatment regimens 52 atypical antipsychotic medication 52 CCR5 receptor antagonist 52 abatacept 52 Hepsera adefovir dipivoxil 52 PNP inhibitor 52 COU AA 52 pegIFN 52 azacitidine 52 enfuvirtide 52 Allovectin 7 ® 52 Virologic 52 Infected Patients 52 malignant pleural mesothelioma 52 cilengitide 52 mildly symptomatic 52 beta2 agonist 52 AZT zidovudine Retrovir 52 TNF antagonists 52 chronic myeloid leukemia CML 52 oral antibiotic 52 alpha 2b 52 Intelence 52 previously untreated follicular 52 severe sepsis 52 CoFactor 52 recurrent glioma 52 SEBIVO 52 docetaxel chemotherapy 52 HBeAg negative patients 52 ceftobiprole 51 canakinumab 51 Dacetuzumab 51 methylnaltrexone 51 gastrointestinal stromal tumor GIST 51 VPRIV 51 coinfected patients 51 Phase 2b study 51 antibody MAb 51 bortezomib 51 JAK inhibitor 51 sodium glucose cotransporter 51 relapsing remitting MS 51 sustained virological response 51 highly immunogenic 51 latent TB 51 functional dyspepsia 51 Acute Myeloid Leukemia AML 51 docetaxel Taxotere R 51 REBETOL 51 SNT-MC#/idebenone 51 integrase inhibitor 51 systemic lupus erythematosus SLE 51 Copegus ® 51 herpes zoster shingles 51 APTIVUS ritonavir 51 Gilead Viread 51 metastatic colorectal cancer 51 oral methylnaltrexone 51 chronic angina 51 elvucitabine 51 Aptivus 51 ELACYT 51 Aflibercept 51 genital ulcer disease 51 lintuzumab SGN 51 Lupuzor ™ 51 humanized anti 51 LymphoStat B TM 51 ACZ# 51 immunosuppressive therapies 51 Phase IIb trial 51 unresectable stage 51 Diamyd ® 51 SCIg 51 lamivudine 3TC 51 MPS IVA 51 CAELYX 51 REYATAZ ® 51 tenofovir DF 51 imatinib Gleevec 51 oral candidiasis 51 FOLFIRI 51 abiraterone acetate 51 Kit CD# positive 51 oral vancomycin 51 hepatocellular carcinoma HCC 51 discontinued Viread 51 rindopepimut 51 acute onset CINV 51 non alcoholic steatohepatitis 51 Nitazoxanide 51 refractory prostate cancer 51 CDAD 51 FOLOTYN 51 Staphylococcus aureus infections 51 HER2 positive metastatic breast 51 systemic lupus erythematosus 51 indinavir Crixivan 51 Myocet 51 virological response 51 Vicriviroc 51 CEQ# 51 Ceftaroline 51 Mipomersen 51 5-FU/LV 51 Daclizumab 51 Locteron 51 chlorambucil 51 nucleoside 51 diagnosed Ph + 51 mcg albinterferon alfa 2b 51 investigational protease inhibitor 51 amphotericin B 51 diabetic macular edema 51 panobinostat 51 imatinib mesylate Gleevec 51 IV bisphosphonates 51 progressive PsA 51 MPS VI 51 lubiprostone 51 Genital herpes 51 LEUKINE 51 cefepime 51 DOXIL 51 tyrosine kinase inhibitor 51 selective modulator 51 trastuzumab DM1 T DM1 51 Levofloxacin 51 Talabostat 51 Torisel 51 genotype 1b 51 blinatumomab 51 atherothrombotic events 51 cutaneous T cell 51 opioid induced constipation 51 combination antiretroviral therapy 51 CCR5 mAb 51 immunomodulatory 51 tenofovir Viread 51 imatinib Gleevec ® 51 NVA# 51 multiple myeloma MM 51 Ozarelix 51 Zerenex 51 adalimumab 51 genital herpes 51 FTC TDF 51 severe oral mucositis 51 uncomplicated influenza 51 achieve sustained virological 51 Fabry Disease 51 atypical Hemolytic Uremic Syndrome 51 HIV infection 51 Baraclude entecavir 51 Engerix B 51 Bezielle 51 Nexavar tablets 51 darunavir ritonavir 51 tigecycline 51 JAK2 Inhibitor 51 Clofarabine 51 Nexavar sorafenib 51 overactive bladder syndrome 51 hypercholesterolemia 51 dose regimen 51 mCRC 51 HBV 51 COMBIVIR 51 RhuDex ® 51 TELINTRA 51 adecatumumab 51 emtricitabine tenofovir 51 B CLL 51 Jevtana 51 Acute Radiation Syndrome ARS 51 telavancin 51 primary immunodeficiency PI 51 VICTRELIS 51 reslizumab 51 ARICEPT 51 antiretroviral medicinal 51 Isentress raltegravir 51 mycophenolate mofetil 51 KRAS mutations occur 51 fludarabine 51 pexiganan 51 trastuzumab Herceptin R 51 Phase IIb trials 51 Peginterferon Alfa 2a 51 riociguat 51 Irinotecan 51 Pirfenidone 51 Cloretazine 51 AmBisome 51 chemotherapy induced neutropenia 51 Peg Intron 51 Cetrorelix 51 pivotal Phase III 51 FOLOTYN ® 51 pegylated interferon ribavirin 51 MYDICAR ® 51 sunitinib Sutent ® 51 aflibercept VEGF Trap 51 Menveo 51 STELARA ™ 51 KETEK 51 Laquinimod 51 alemtuzumab treated 51 dasatinib 51 C1 inhibitor deficiency 51 Amgen Neulasta R 51 log# reduction 51 latent tuberculosis infection 51 Zolinza 51 Rituxan rituximab 51 metformin sulfonylurea 51 postherpetic neuralgia 51 Naive Patients 51 pre exposure prophylaxis 51 BAY #-# 51 pegloticase 51 FASLODEX 51 Allovectin 7 51 EOquin 51 Phase 2b trial 51 Interferon alfa 51 SJIA 51 generation NNRTI 51 Prezista 51 refractory angina 51 bevacizumab Avastin ® 51 relapsed leukemia 51 Insegia 51 Peginterferon alfa 2b 51 tofacitinib 51 MAXY alpha 51 Alferon LDO 51 Gleevec imatinib 51 nevirapine Viramune 51 T2DM 51 torezolid phosphate 51 Epivir 51 efavirenz EFV 51 REMICADE ® 51 REVLIMID lenalidomide 51 pralatrexate 51 hypercalcemia 51 congenital ichthyosis 50 clofarabine 50 ribavirin USP 50 prophylactic treatment 50 vicriviroc 50 non splenectomized 50 diabetic macular edema DME 50 viral subtypes 50 recurrent ovarian cancer 50 meropenem 50 Phase 1b 50 xanthine oxidase inhibitor 50 co trimoxazole 50 NNRTIs 50 cystic fibrosis bronchiectasis 50 Voreloxin 50 interferon gamma 1b 50 CMV retinitis 50 CIMZIA TM 50 multi kinase inhibitor 50 genotype 1a 50 cabazitaxel 50 pertuzumab 50 iclaprim 50 voreloxin 50 acetonide FA 50 Doxil ® 50 Community Acquired Pneumonia 50 tyrosine kinase inhibitor TKI 50 VivaGel ™ 50 AGILECT R 50 GSK# [002] 50 cangrelor 50 CYT# potent vascular disrupting 50 HAART 50 nucleoside naive 50 cirrhosis liver failure 50 dirucotide 50 amprenavir 50 bortezomib Velcade R 50 Tasigna nilotinib 50 prokinetic agent 50 mapatumumab 50 dimebon 50 Pegylated Interferon 50 JANUMET 50 posterior uveitis 50 NRTI backbone 50 Phase 2a clinical 50 stavudine 50 thymalfasin 50 uric acid lowering 50 refractory cutaneous T 50 oral prodrug 50 humanized monoclonal antibody 50 Golimumab 50 investigational monoclonal antibody 50 virologic suppression 50 Cycloset 50 NATRECOR ® 50 gastrointestinal stromal tumors 50 Alzhemed TM 50 Eraxis 50 hepatocellular cancer 50 gemcitabine Gemzar 50 ZOLINZA 50 aflibercept 50 exenatide injection 50 Viread 50 ORENCIA ® 50 trastuzumab Herceptin ® 50 Allovectin 7 R 50 relapsed SCLC 50 bosutinib 50 refractory acute myeloid 50 tinidazole 50 gefitinib Iressa 50 Taxotere ® 50 RRMS patients 50 Pralatrexate 50 REMUNE R 50 phase IIb clinical 50 interleukin IL -# 50 metastatic kidney 50 HuLuc# 50 Telzir 50 SYMBICORT 50 ROTATEQ 50 synthetic retinoid 50 mCRC patients 50 bevacizumab Avastin 50 de novo kidney transplant 50 Entecavir 50 imipenem 50 ridaforolimus 50 atopic dermatitis 50 targeting CD# 50 lapatinib Tykerb 50 teduglutide 50 HCV polymerase inhibitor 50 noninfectious uveitis 50 Arcalyst 50 oral antiviral 50 rituximab 50 bone metastases 50 PREZISTA 50 Degarelix 50 peg interferon 50 REBETOL combination therapy 50 oxymorphone ER 50 chronic myelogenous leukemia CML 50 Crohn disease 50 nucleoside analogues 50 conjugate vaccine 50 stage IIIB IV 50 carfilzomib 50 cancer cachexia 50 investigational immunotherapy 50 paclitaxel Taxol 50 cSSSIs 50 peginterferon alfa 2a #KD 50 PEGylated Fab fragment 50 dyslipidemia 50 lipohypertrophy 50 Valopicitabine 50 IBS C 50 phase IIa 50 NYHA Class II 50 TYKERB 50 ALN TTR 50 Cimzia ® 50 Actemra 50 opioid induced constipation OIC 50 Valcyte tablets 50 Renal Cell Carcinoma RCC 50 Perifosine 50 cell malignancies 50 Dacogen injection 50 Bortezomib 50 SAR# [004] 50 palifosfamide 50 TNF inhibitor 50 benazepril 50 hereditary antithrombin deficiency 50 ZOSTAVAX 50 chronic periodontitis 50 Hizentra 50 lumiliximab 50 Kaletra lopinavir ritonavir 50 beclomethasone dipropionate 50 R emtricitabine 50 cetuximab Erbitux R 50 FOSRENOL R 50 Amgen Neulasta ® 50 teriflunomide 50 Chlamydia trachomatis 50 HEPLISAV 50 DPNP 50 omalizumab 50 metastatic malignant melanoma 50 Aviptadil 50 lintuzumab 50 hormone deprivation 50 interferons 50 VIRAMUNE XR 50 hour bronchodilation 50 Helicobacter pylori H. pylori 50 ABILIFY ® 50 advanced metastatic renal 50 linezolid 50 venous thromboembolic events 50 Hodgkin lymphoma HL 50 azathioprine 50 IV metastatic melanoma 50 Gammagard 50 atazanavir Reyataz 50 refractory metastatic colorectal cancer 50 HoFH 50 BCR ABL inhibitors 50 otelixizumab 50 Dalbavancin 50 Cimzia TM 50 Phase Ib IIa 50 Vectibix 50 ZIAGEN 50 RSD# 50 resistant ovarian cancer 50 post herpetic neuralgia 50 SIMPONI 50 refractory PTCL 50 PEG INTRON 50 pegylated 50 Phase Ib clinical 50 dose escalation clinical 50 Relapsed Refractory 50 oral mucositis 50 Phase 1b clinical 50 RG# [001] 50 MAGE A3 ASCI 50 PANVAC VF 50 methicillin resistant S. aureus 50 Severe Primary IGFD 50 refractory CML 50 dapsone 50 Clolar ® 50 refractory chronic myeloid 50 vidofludimus 50 severe plaque psoriasis 50 AIDS Clinical Trials 50 metastatic HRPC 50 phenylketonuria PKU 50 oral rivaroxaban 50 diabetic kidney 50 Advanced Melanoma 50 renal cell carcinoma 50 FavId 50 grade cervical intraepithelial 50 simplex virus 50 sodium stibogluconate 50 rilonacept 50 Helicobacter pylori eradication 50 CERVARIX 50 Tindamax R 50 suppressive therapy 50 hematological cancers 50 pain palliation 50 severe neutropenia 50 darapladib 50 RoACTEMRA 50 immune modulators 50 ONGLYZA 50 stavudine d4T 50 severe hypercholesterolemia 50 mg/m2 dose 49 Crohn disease CD 49 Emtriva 49 aHUS 49 ADHF 49 paclitaxel Taxol R 49 anthracycline containing 49 Neovascular Age Related Macular 49 8mg/kg 49 metastatic pancreatic cancer 49 naproxen esomeprazole magnesium 49 ofatumumab 49 oral herpes 49 CIMZIA TM certolizumab pegol 49 lopinavir r arm 49 ISTODAX ® 49 Gleevec resistant 49 administered subcutaneously 49 TDF FTC 49 ZFP Therapeutic 49 chronic gout 49 CLL SLL 49 daclizumab 49 BRIM3 49 rFIXFc 49 VIDAZA 49 efavirenz emtricitabine 49 sJIA 49 HIV 49 neuraminidase inhibitor